Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9189 | 1111 | 37.3 | 75% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
520 | 14322 | SOLID LIPID NANOPARTICLES//NANOSTRUCTURED LIPID CARRIERS//NANOSUSPENSION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SEDDS | Author keyword | 87 | 86% | 4% | 44 |
2 | SMEDDS | Author keyword | 80 | 80% | 4% | 49 |
3 | SELF MICROEMULSIFYING DRUG DELIVERY SYSTEM | Author keyword | 79 | 88% | 3% | 37 |
4 | SNEDDS | Author keyword | 65 | 84% | 3% | 36 |
5 | SELF EMULSIFYING DRUG DELIVERY SYSTEMS | Author keyword | 65 | 93% | 2% | 25 |
6 | SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM | Author keyword | 59 | 90% | 2% | 26 |
7 | SELF EMULSIFYING DRUG DELIVERY SYSTEM | Author keyword | 42 | 78% | 3% | 28 |
8 | LIPID BASED FORMULATIONS | Author keyword | 38 | 69% | 3% | 33 |
9 | DRY EMULSION | Author keyword | 36 | 77% | 2% | 24 |
10 | SELF EMULSIFYING SYSTEMS | Author keyword | 35 | 89% | 1% | 16 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LIPOPHILIC DRUGS | 235 | 64% | 21% | 231 |
2 | SEDDS | 197 | 94% | 6% | 72 |
3 | SMEDDS | 122 | 88% | 5% | 58 |
4 | SNEDDS | 122 | 95% | 4% | 40 |
5 | LIPID BASED FORMULATIONS | 84 | 60% | 8% | 91 |
6 | INTESTINAL LYMPHATIC TRANSPORT | 48 | 62% | 5% | 50 |
7 | BIOAVAILABILITY ASSESSMENT | 40 | 59% | 4% | 45 |
8 | SELF EMULSIFYING FORMULATIONS | 37 | 100% | 1% | 14 |
9 | FLOW BLOCKING APPROACH | 31 | 92% | 1% | 12 |
10 | SOLID STATE EMULSIONS | 31 | 92% | 1% | 12 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Lipid-based formulations for oral administration of poorly water-soluble drugs | 2013 | 25 | 103 | 69% |
Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability | 2010 | 72 | 48 | 75% |
Immunosuppressive drug therapy - biopharmaceutical challenges and remedies | 2015 | 1 | 86 | 27% |
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs | 2007 | 452 | 210 | 28% |
Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances | 2010 | 65 | 102 | 59% |
Recent Advances in Self-Emulsifying Drug Delivery Systems (SEDDS) | 2014 | 3 | 115 | 80% |
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs | 2004 | 359 | 71 | 46% |
Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms | 2008 | 94 | 45 | 67% |
Lipid-Based Formulations and Drug Supersaturation: Harnessing the Unique Benefits of the Lipid Digestion/Absorption Pathway | 2013 | 11 | 49 | 59% |
Oral lipid-based formulations | 2007 | 168 | 49 | 49% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIONEER FARMA | 6 | 34% | 1.4% | 15 |
2 | PHARMA TECHNOL | 4 | 25% | 1.4% | 15 |
3 | BIONEER FARMADANISH DRUG DEV | 3 | 100% | 0.3% | 3 |
4 | ARC SPECIAL PARTICLE MAT | 2 | 67% | 0.2% | 2 |
5 | DANISH DRUG DEV BIONEER FARMA | 2 | 67% | 0.2% | 2 |
6 | UGC EXCELLENCE NANO PLICAT BIOMED SCI | 2 | 67% | 0.2% | 2 |
7 | KAYYALI CHAIR PHARMACEUT IND | 2 | 13% | 1.3% | 14 |
8 | PREFORMULAT | 2 | 18% | 0.9% | 10 |
9 | PHARMACEUT FORMULAT DESIGN | 1 | 38% | 0.3% | 3 |
10 | UGC EXCELLENCE PLICAT NANOMAT NANOPARTICLES | 1 | 38% | 0.3% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000278782 | MICROEMULSION//MICROEMULSIONS//OIDS SUR ES |
2 | 0.0000140346 | DISSOLUTION TECHNOLOGIES//BIORELEVANT MEDIA//BIOWAIVER |
3 | 0.0000125314 | SOLID DISPERSIONS//HOT MELT EXTRUSION//AMORPHOUS SOLID DISPERSION |
4 | 0.0000120498 | NANO EMULSIONS//NANOEMULSION//EMULSIFICATION EVAPORATION |
5 | 0.0000118247 | LIPID IMPLANTS//SOLID LIPID EXTRUSION//LIPID MATRICES |
6 | 0.0000112299 | SOLID LIPID NANOPARTICLES//NANOSTRUCTURED LIPID CARRIERS//SOLID LIPID NANOPARTICLE |
7 | 0.0000107360 | NANOSUSPENSION//NANOSUSPENSIONS//WET MEDIA MILLING |
8 | 0.0000103852 | ENTEROSTATIN//COLIPASE//GASTRIC LIPASE |
9 | 0.0000081202 | CACO 2//SINGLE PASS INTESTINAL PERFUSION//INTESTINAL PERFUSION |
10 | 0.0000078573 | SODIUM CAPRATE//SUPPOSITORY//ABSORPTION ENHANCER |